1. P11 Characteristics and long-term real-world outcomes of severe asthma patients treated with benralizumab in the United Kingdom; the BPAP study. (11th November 2022) Authors: Jackson, DJ; Burhan, H; Menzies-Gow, A; Rupani, H; Pfeffer, PE; Clifton, IJ; Faruqi, S; Nanzer, AM; Dhariwal, J; Morris, T; Lipworth, J; Watt, M Journal: Thorax Issue: Volume 77(2022)Supplement 1 Page Start: A86 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P12 A FeNO-based strategy to guide oral corticosteroid initiation in patients with severe asthma experiencing an exacerbation whilst on treatment with anti-IL5/5R therapy. (11th November 2022) Authors: Lam, JL; Hearn, AP; Thomson, LA; Green, LM; Fernandes, M; Roxas, C; D'Ancona, G; Dhariwal, J; Nanzer, AM; Jackson, DJ Journal: Thorax Issue: Volume 77(2022)Supplement 1 Page Start: A87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P13 T2 biomarker-guided oral corticosteroid weaning in asthma. (11th November 2022) Authors: Thomson, LA; Hearn, AP; Lam, JL; Fernandes, M; Green, LM; Roxas, C; D'Anconna, G; Dhariwal, J; Nanzer, AM; Jackson, DJ Journal: Thorax Issue: Volume 77(2022)Supplement 1 Page Start: A87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P193 A role for active Vitamin D in steroid resistant asthma patients who have enhanced production of IL-17A and reduced IL-10. (14th November 2013) Authors: Nanzer, AM; Chambers, ES; Richards, DF; Martineau, AR; Griffiths, CJ; Corrigan, C; Hawrylowicz, CM Journal: Thorax Issue: Volume 68(2013)Supplement 3 Page Start: A163 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P193 Quantifying the unmet need in severe asthma: An analysis of the number of untreated biologic eligible patients in the UK. (11th November 2022) Authors: Dhruve, H; Haigh, M; Nanzer, AM; Jackson, DJ Journal: Thorax Issue: Volume 77(2022)Supplement 1 Page Start: A185 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P210 The impact of introducing anti-IL-5/5R biologic therapies on weight and BMI in prednisolone-dependent patients with severe asthma. (11th November 2022) Authors: Taylor, VM; Patrick, T; Hearn, AP; Kavanagh, JE; Thomson, LA; Lam, JL; Green, LM; Fernandes, M; Roxas, C; d'Ancona, G; Dhariwal, J; Jackson, DJ; Nanzer, AM Journal: Thorax Issue: Volume 77(2022)Supplement 1 Page Start: A194 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P213 Real-world effectiveness of benralizumab in patients with eosinophilic granulomatosis with polyangiitis (EGPA). (11th November 2022) Authors: Alam, V; Agarwal, S; Hopkins, C; D'cruz, D; Fernando, MMA; Ismail, TF; Dhariwal, J; Nanzer, AM; Jackson, DJ Journal: Thorax Issue: Volume 77(2022)Supplement 1 Page Start: A195 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P86 Does adherence to ICS/LABA therapy change following initiation of Benralizumab in the treatment of severe asthma and does this affect outcome?. (12th November 2019) Authors: d'Ancona, G; Bains, S; Bakrania, P; Green, L; Fernandes, M; Roxas, C; Thomson, L; Osman, L; Stewart-Knight, K; Dhariwal, J; Nanzer, AM; Kavanagh, J; Jackson, DJ; Kent, BD Journal: Thorax Issue: Volume 74(2019)Supplement 2 Page Start: A136 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P88 Real-world effectiveness of anti-IL-5/5R therapies in severe atopic eosinophilic asthmatics eligible for anti-IgE therapy. (12th November 2019) Authors: Jackson, DJ; Kavanagh, J; Roxas, C; D'Ancona, G; Green, L; Thomson, L; Fernandes, M; Dhariwal, J; Nanzer, AM; Kent, BD Journal: Thorax Issue: Volume 74(2019)Supplement 2 Page Start: A137 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P89 Real-world 1 year effectiveness of benralizumab in severe eosinophilic asthma. (12th November 2019) Authors: Kavanagh, J; Roxas, C; Thomson, L; Fernandes, M; Green, L; d'Ancona, G; Dhariwal, J; Nanzer, AM; Kent, BD; Jackson, DJ Journal: Thorax Issue: Volume 74(2019)Supplement 2 Page Start: A138 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗